Authors

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Fair Market Value vs. Current Market Leverage

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Why Pharmaceutical Products Need Sustainable Packaging

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered

Why the life science industry needs to move away from omnichannel marketing strategies and toward optichannel approaches that boost personalization and ROI in an era of shrinking budgets.

AI-Fueled Counterfeiting Surges as Pharma Confronts Rising Digital Threats

In a video interview with Pharma Commerce, Mark Lee, Marqvision’s founder and CEO, and Sean O’Hearen, founder and principal consultant at 1st Line Partners, warn that counterfeiters are rapidly leveraging AI to create fake websites, social profiles, and manipulated product content—outpacing traditional protections and highlighting widespread underreporting of falsified medicines.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Streamlining Clinical Trials with Site Augmentation

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.

How Organizations Can Build a True Culture of Compliance

In final part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, points out how leadership buy-in, role-based training, and “cyber moments” can reinforce continuous awareness and shared responsibility across the organization.

The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet

Why startups and life sciences companies should approach this booming sector with extreme caution.

Empowering Patients as Partners: The Next Frontier for Pharma Companies

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

A 'Beautiful Fake': Pharma Fraudsters Upping Their Game

Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global trade gaps—making detection harder and patient risk greater than ever.

AI’s Next Step in Pharma Quality: From Detection to Closed-Loop Prevention

In the final part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, explains that as pharma quality systems evolve, AI is shifting from reactive problem-solving to proactive, closed-loop risk prevention, enhancing operator insight, decision-making, and continuous process improvement.

Revolutionizing Pharma Patient Assistance Programs, KnippeRx Leads the Future of Patient Care

How the Rise in Self-Injectables Is Impacting Pharmaceutical Manufacturing

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

Why well-organized documentation is critical at every stage of the process.

Addressing the Threat of Prescription Abandonment

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?

WISeR Spending or Unneeded Delays in Healthcare? Prior Authorizations, AI in Medicare Prompt Concerns

The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.

How AI Orchestration Is Reinventing Healthcare Supply Chain Resilience

By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to move from reactive firefighting to proactive resilience—supporting faster responses, smarter tradeoffs, and more reliable patient care delivery.

Why Trust Is the Biggest Barrier to Supply Chain Transparency

In the final part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, explains how federated intelligence, audit-ready data systems, and a culture of compliance are enabling scalable transparency across decentralized pharmaceutical manufacturing networks.

From Uncertainty to Opportunity: Navigating IPAY 2028

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care

What Will Actually Bend the Healthcare Cost Curve?

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, points out that from biosimilars and site-of-care shifts to AI, value-based reimbursement, and potential legislative action, market deflators—not simple cost shifting—will determine whether affordability improves across employer-sponsored plans, Medicaid, and Medicare.

De-Risking Clinical Development: Strategic Multipliers in Global Trials

How Biopharma Companies Can Optimize Field Reimbursement Models

In the final part of her Pharma Commerce video interview, Megan Wetzel, VP, product, access & affordability at CoverMyMeds, shares how the right field reimbursement model structure ensures field teams have the insights and tools they need to overcome coverage barriers and accelerate patient access to therapy.

Novo Nordisk Signals Future Wegovy Vial Launch

The GLP-1 landscape continues to evolve in both delivery formats and affordability.

A Practitioner’s Guide to AI Lifecycle Management in Life Sciences

This guide outlines a proven framework, spanning process, people, and platform, to help healthcare innovators scale AI with compliance, collaboration, and clinical impact in mind.

Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation Expertise

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.